FDA Drug Application (021330) for COMMIT by GLAXOSMITHKLINE CONS

Back to FDA Applications sponsored by GLAXOSMITHKLINE CONS

Application Number021330
Product Number001
FormTROCHE/LOZENGE;ORAL
DosageEQ 2MG BASE
Product Market Status Over The Counter
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameCOMMIT
Active IngredientNICOTINE POLACRILEX



Back to FDA Applications sponsored by GLAXOSMITHKLINE CONS

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.